Mark Jacobson, M.A.

Mark Jacobson, M.A.

Chief Operating OfficeratAxsome Therapeutics· In proxies 2021–2025

Pay in FY2025-1% from the year before · Axsome Therapeutics stock +115.9% the same year

Mark Jacobson, M.A. was paid $4.2M in FY2025 (Dec), down 1%. Axsome Therapeutics stock rose 115.9% that year.

Pay$100 in the stock at the end of FY20 → $224
Pay is from the Summary Compensation Table of each Axsome Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Axsome TherapeuticsPublic company · 5 yr
    • Chief Operating Officer2021 – Present · 5 yrStock in role +69%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?